Growth Metrics

Eledon Pharmaceuticals (ELDN) Leases (2019 - 2026)

Eledon Pharmaceuticals posted quarterly Leases of $530000.0 for Q1 2026, down 37.65% year-on-year from $850000.0 in Q1 2025, and down 13.54% on a QoQ basis from $613000.0 in Q4 2025.

Eledon Pharmaceuticals (ELDN) has 8 years of Leases data on file, last reported at $530000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Leases fell 37.65% year-over-year to $530000.0; the trailing twelve-month figure through Mar 2026 stood at $530000.0 (down 37.65% YoY), and the FY2025 full-year result was $613000.0, down 33.8% from the prior year.
  • Leases for Q1 2026 stood at $530000.0, down from $613000.0 in the prior quarter.
  • Across five years, Leases topped out at $926000.0 in Q4 2024 and bottomed at $270000.0 in Q1 2024.
  • The 5-year median for Leases is $621000.0 (2024), against an average of $623470.6.
  • The widest annual swing landed in 2022, when Leases jumped 633.7%; it then sank 58.27% in 2024.
  • A 5-year view of Leases shows it stood at $739000.0 in 2022, then slumped by 50.61% to $365000.0 in 2023, then jumped by 153.7% to $926000.0 in 2024, then plunged by 33.8% to $613000.0 in 2025, then decreased by 13.54% to $530000.0 in 2026.
  • The last three Leases figures came in at $530000.0 (Q1 2026), $613000.0 (Q4 2025), and $694000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - 530,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 530,000.00
Dec 31, 2025 613,000.00
Sep 30, 2025 694,000.00
Jun 30, 2025 773,000.00
Mar 31, 2025 850,000.00
Dec 31, 2024 926,000.00
Sep 30, 2024 471,000.00
Jun 30, 2024 621,000.00
Mar 31, 2024 270,000.00
Dec 31, 2023 365,000.00
Sep 30, 2023 459,000.00
Jun 30, 2023 553,000.00
Mar 31, 2023 647,000.00
Dec 31, 2022 739,000.00
Sep 30, 2022 832,000.00
Jun 30, 2022 581,000.00
Mar 31, 2022 675,000.00
Dec 31, 2021 768,000.00
Sep 30, 2021 222,000.00
Jun 30, 2021 267,000.00
Mar 31, 2021 92,000.00
Dec 31, 2020 138,000.00
Sep 30, 2020 183,000.00
Jun 30, 2020 228,000.00
Mar 31, 2020 272,000.00
Dec 31, 2019 316,000.00
Sep 30, 2019 360,000.00
Jun 30, 2019 403,000.00
Mar 31, 2019 446,000.00